Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001744560-19-000001
Filing Date
2019-10-04
Accepted
2019-10-04 13:55:12
Documents
1
Effectiveness Date
2019-10-04
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 6440
  Complete submission text file 0001744560-19-000001.txt   7486
Mailing Address 215 FIRST STREET, SUITE 401S CAMBRIDGE MA 02142
Business Address 215 FIRST STREET, SUITE 401S CAMBRIDGE MA 02142 (857) 776-7400
Celsius Therapeutics, Inc. (Filer) CIK: 0001744560 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-315973 | Film No.: 191138334